Literature DB >> 24095843

Modeling neurodegenerative diseases in Caenorhabditis elegans.

Jia Li1, Weidong Le.   

Abstract

Neurodegenerative diseases which include Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington disease (HD), and others are becoming an increasing threat to human health worldwide. The degeneration and death of certain specific groups of neurons are the hallmarks of these diseases. Despite the research progress in identification of several disease-related genes, the mechanisms underlying the neurodegeneration in these diseases remain unclear. Given the molecular conservation in neuronal signaling between Caenorhabditis elegans and vertebrates, an increasing number of research scientists have used the nematode to study this group of diseases. This review paper will focus on the model system that has been established in C. elegans to investigate the pathogenetic roles of those reported disease-related genes in AD, PD, ALS, HD and others. The progress in C. elegans provides useful information of the genetic interactions and molecular pathways that are critical in the disease process, and may help better our understanding of the disease mechanisms and search for new therapeutics for these devastating diseases.
© 2013.

Entities:  

Keywords:  Alzheimer's disease (AD); Amyotrophic lateral sclerosis (ALS); Caenorhabditis elegans; Huntington's disease (HD); Model organism; Neurodegeneration; Parkinson's disease (PD)

Mesh:

Year:  2013        PMID: 24095843     DOI: 10.1016/j.expneurol.2013.09.024

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  36 in total

1.  Mass Histology to Quantify Neurodegeneration in Drosophila.

Authors:  Elizabeth R Sunderhaus; Doris Kretzschmar
Journal:  J Vis Exp       Date:  2016-12-15       Impact factor: 1.355

2.  Insulin Signaling Deficiency Produces Immobility in Caenorhabditis elegans That Models Diminished Motivation States in Man and Responds to Antidepressants.

Authors:  Julie Dagenhardt; Angeline Trinh; Halen Sumner; Jeffrey Scott; Eric Aamodt; Donard S Dwyer
Journal:  Mol Neuropsychiatry       Date:  2017-09-21

Review 3.  Pathways to neurodegeneration: lessons learnt from unbiased genetic screens in Drosophila.

Authors:  Neha Singhal; Manish Jaiswal
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

4.  Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease.

Authors:  Waqar Ahmad; Paul R Ebert
Journal:  Mol Neurobiol       Date:  2016-09-05       Impact factor: 5.590

5.  Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease.

Authors:  William M Johnson; Chen Yao; Sandra L Siedlak; Wenzhang Wang; Xiongwei Zhu; Guy A Caldwell; Amy L Wilson-Delfosse; John J Mieyal; Shu G Chen
Journal:  Hum Mol Genet       Date:  2014-10-29       Impact factor: 6.150

6.  Mutation of hop-1 and pink-1 attenuates vulnerability of neurotoxicity in C. elegans: the role of mitochondria-associated membrane proteins in Parkinsonism.

Authors:  Siyu Wu; Lili Lei; Yang Song; Mengting Liu; Shibo Lu; Dan Lou; Yonghong Shi; Zhibin Wang; Defu He
Journal:  Exp Neurol       Date:  2018-08-01       Impact factor: 5.330

7.  Automated high-content phenotyping from the first larval stage till the onset of adulthood of the nematode Caenorhabditis elegans.

Authors:  Huseyin Baris Atakan; Matteo Cornaglia; Laurent Mouchiroud; Johan Auwerx; Martin A M Gijs
Journal:  Lab Chip       Date:  2018-12-18       Impact factor: 6.799

8.  Using WormBase: A Genome Biology Resource for Caenorhabditis elegans and Related Nematodes.

Authors:  Christian Grove; Scott Cain; Wen J Chen; Paul Davis; Todd Harris; Kevin L Howe; Ranjana Kishore; Raymond Lee; Michael Paulini; Daniela Raciti; Mary Ann Tuli; Kimberly Van Auken; Gary Williams
Journal:  Methods Mol Biol       Date:  2018

9.  Reactive oxygen species-mediated neurodegeneration is independent of the ryanodine receptor in Caernorhabditis elegans.

Authors:  Lyndsay Ea Young; Daniel C Williams
Journal:  J S C Acad Sci       Date:  2015

Review 10.  Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.

Authors:  Todd E Golde
Journal:  J Neurochem       Date:  2016-05-04       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.